{"disease":{"id":"malignant-tumor-of-the-ovary","name":"malignant tumor of the ovary"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02601950","title":"A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"Epizyme, Inc.","has_results":true},{"nct_id":"NCT05642871","title":"DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene","phase":"","overall_status":"UNKNOWN","enrollment_count":2,"lead_sponsor_name":"Qianqian Qu","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}